Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Mia Arnhult — Board member

Roles

Devyser Diagnostics AB Stockholm
Board member
04.09.2025 – 10.06.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
10.06.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
76,251SEK 92.00
SEK 7,015,092.00
↗
10.06.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
10,000SEK 97.40
SEK 974,000.00
↗
02.06.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
76,251SEK 92.00
SEK 7,015,092.00
↗
26.05.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
10,000SEK 97.40
SEK 974,000.00
↗
20.03.2026Devyser Diagnostics AB Stockholm
Bought — open marketAcquisition
500SEK 77.00
SEK 38,500.00
↗
18.03.2026Devyser Diagnostics AB Stockholm
Bought — open marketAcquisition
500SEK 79.26
SEK 39,630.00
↗
18.03.2026Devyser Diagnostics AB Stockholm
Bought — open marketAcquisition
500SEK 79.40
SEK 39,700.00
↗
04.03.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
9,802SEK 98.50
SEK 965,497.00
↗
18.02.2026Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
9,802SEK 98.50
SEK 965,497.00
↗
21.11.2025Devyser Diagnostics AB Stockholm
Bought — open marketAcquisition
via M2 Asset Management AB
135SEK 104.85
SEK 14,154.75
↗
07.11.2025Devyser Diagnostics AB Stockholm
Bought — open marketAcquisition
via M2 Asset Management AB
14,084SEK 110.40
SEK 1,554,873.60
↗
11.09.2025Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
41,596SEK 149.60
SEK 6,222,761.60
↗
04.09.2025Devyser Diagnostics AB Stockholm
Pledge
via M2 Asset Management AB
41,596SEK 149.60
SEK 6,222,761.60
↗